Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Immutep Limited Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B April 24, 2024 From Immutep Limited Via GlobeNewswire Tickers ASX:IMM IMMP Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023 October 24, 2023 From Immutep Limited Via GlobeNewswire Tickers ASX:IMM IMMP Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer October 23, 2023 From Immutep Limited Via GlobeNewswire Tickers ASX:IMM IMMP Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer May 17, 2023 From Immutep Limited Via GlobeNewswire Tickers ASX:IMM IMMP Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO® May 01, 2023 From Immutep Limited Via GlobeNewswire Tickers ASX:IMM IMMP Immutep Enters into Second Clinical Trial Collaboration Agreement with Merck KGaA, Darmstadt, Germany, and Pfizer for New Combination Study of its First-in-Class LAG-3 Candidate, Eftilagimod Alpha, and Avelumab to Treat Urothelial Cancer November 29, 2022 From Immutep Limited Via GlobeNewswire Tickers ASX:IMM IMMP Immutep Granted New Patents in Japan and South Korea for First-in-Class LAG-3 Candidate, Eftilagimod Alpha in Chemo-Immunotherapy Combination November 09, 2022 From Immutep Limited Via GlobeNewswire Tickers ASX:IMM IMMP Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
